WO2002002797A3 - Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme - Google Patents

Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme Download PDF

Info

Publication number
WO2002002797A3
WO2002002797A3 PCT/EP2001/007632 EP0107632W WO0202797A3 WO 2002002797 A3 WO2002002797 A3 WO 2002002797A3 EP 0107632 W EP0107632 W EP 0107632W WO 0202797 A3 WO0202797 A3 WO 0202797A3
Authority
WO
WIPO (PCT)
Prior art keywords
beta
human
enzyme
hydroxysteroid dehydrogenase
regulation
Prior art date
Application number
PCT/EP2001/007632
Other languages
French (fr)
Other versions
WO2002002797A2 (en
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Ag
Shyam Ramakrishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Shyam Ramakrishnan filed Critical Bayer Ag
Priority to AU2001276378A priority Critical patent/AU2001276378A1/en
Priority to JP2002508037A priority patent/JP2004502432A/en
Priority to EP01954005A priority patent/EP1309697A2/en
Publication of WO2002002797A2 publication Critical patent/WO2002002797A2/en
Publication of WO2002002797A3 publication Critical patent/WO2002002797A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01146—11-Beta-hydroxysteroid dehydrogenase (1.1.1.146)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Reagents which regulate human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme and reagents which bind to human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to CNS disorders, osteoporosis, liver disease, obesity, blood pressure or fetal development abnormalities, and diabetes.
PCT/EP2001/007632 2000-07-05 2001-07-04 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme WO2002002797A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001276378A AU2001276378A1 (en) 2000-07-05 2001-07-04 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
JP2002508037A JP2004502432A (en) 2000-07-05 2001-07-04 Regulation of human 11β-hydroxysteroid dehydrogenase 1-like enzyme
EP01954005A EP1309697A2 (en) 2000-07-05 2001-07-04 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21635000P 2000-07-05 2000-07-05
US60/216,350 2000-07-05
US23129500P 2000-09-08 2000-09-08
US60/231,295 2000-09-08

Publications (2)

Publication Number Publication Date
WO2002002797A2 WO2002002797A2 (en) 2002-01-10
WO2002002797A3 true WO2002002797A3 (en) 2003-02-27

Family

ID=26910926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007632 WO2002002797A2 (en) 2000-07-05 2001-07-04 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme

Country Status (4)

Country Link
EP (1) EP1309697A2 (en)
JP (1) JP2004502432A (en)
AU (1) AU2001276378A1 (en)
WO (1) WO2002002797A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239398A1 (en) * 2000-11-30 2002-06-11 Millenium Pharmaceuticals, Inc. 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
EP1597267A4 (en) * 2003-02-21 2007-04-18 Merck & Co Inc Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues
JP2006523311A (en) * 2003-03-12 2006-10-12 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 37748, 47161, 81982 or Methods and compositions for treating AIDS and HIV related disorders using 46777
US7501405B2 (en) 2003-04-11 2009-03-10 High Point Pharmaceuticals, Llc Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
WO2004089416A2 (en) * 2003-04-11 2004-10-21 Novo Nordisk A/S Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
EP1862181A3 (en) * 2003-04-11 2010-09-15 High Point Pharmaceuticals, LLC New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof
WO2005119525A1 (en) * 2004-06-04 2005-12-15 Pfizer Products Inc. 11βHSD1 CRYSTAL STRUCTURES FOR STRUCTURE BASED DRUG DESIGN
WO2006059507A1 (en) * 2004-11-30 2006-06-08 Sankyo Company, Limited 11β-HSD1 ANTISENSE COMPOUND
CA2630665C (en) 2005-11-21 2011-03-15 Shionogi & Co., Ltd. Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i
JP4671369B2 (en) 2007-05-18 2011-04-13 塩野義製薬株式会社 Nitrogen-containing heterocyclic derivatives having type I 11β-hydroxysteroid dehydrogenase inhibitory activity
MX2011005037A (en) 2008-11-21 2011-06-16 High Point Pharmaceuticals Llc Adamantyl benzamide compounds.
US8513430B2 (en) 2010-07-27 2013-08-20 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965372A (en) * 1995-08-24 1999-10-12 Baker Medical Research Institute Genetic sequences encoding glucocorticoid dehydrogenases and uses thereof
WO2001090090A1 (en) * 2000-05-22 2001-11-29 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965372A (en) * 1995-08-24 1999-10-12 Baker Medical Research Institute Genetic sequences encoding glucocorticoid dehydrogenases and uses thereof
WO2001090090A1 (en) * 2000-05-22 2001-11-29 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 11 November 1999 (1999-11-11), XP002217921, Database accession no. AW163684 *
HULT M ET AL: "Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 441, no. 1, 11 December 1998 (1998-12-11), pages 25 - 28, XP004258864, ISSN: 0014-5793 *
KROZOWSKI ZYGMUNT: "The 11beta-hydroxysteroid dehydrogenases: Functions and physiological effects.", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 151, no. 1-2, 25 May 1999 (1999-05-25), pages 121 - 127, XP002217920, ISSN: 0303-7207 *
STEWART P M ET AL: "11BETA-HYDROXYSTEROID DEHYDROGENASE", VITAMINS AND HORMONES, ACADEMIC PRESS, NEW YORK, NY,, US, vol. 57, 1999, pages 249 - 324, XP001004592, ISSN: 0083-6729 *

Also Published As

Publication number Publication date
WO2002002797A2 (en) 2002-01-10
JP2004502432A (en) 2004-01-29
AU2001276378A1 (en) 2002-01-14
EP1309697A2 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
WO2002002797A3 (en) Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
WO2002036754A3 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
WO2002061092A3 (en) Regulation of human lysyl oxidase
WO2002072824A3 (en) Human transient receptor potential channel protein.
WO2002000855A3 (en) Regulation of human s-acyl fatty acid synthase thioesterase-like enzyme
WO2001077149A3 (en) Regulation of human cyslt2-like gpcr protein
WO2002048325A3 (en) Regulation of human serine palmitoyltransferase
WO2002002755A3 (en) Regulation of human thimet oligopeptidase-like enzyme
WO2002031160A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002031162A3 (en) Regulation of human phospholipase a2-like enzyme
WO2002042435A3 (en) Regulation of human tyrosine phosphatase
WO2002031161A3 (en) Regulation of human phospholipase-like enzyme
WO2002031125A3 (en) Human phospholipase a2-like enzyme
WO2002062974A3 (en) Regulation of human elongase hselo1-like protein
WO2002055710A3 (en) Regulation of human purple acid phosphatase
WO2002020747A3 (en) Regulation of human tyrosine phosphatase-like enzyme
WO2002006454A3 (en) Regulation of human carboxylesterase-like enzyme
WO2002036613A3 (en) Regulation of human patched-like protein
WO2002036731A3 (en) Human lysosomal acid lipase
WO2002024878A3 (en) Human e3 ubiquitin protein ligase-like enzyme
WO2002062975A3 (en) Regulation of human elongase hselo1-like protein
WO2002033080A3 (en) Regulation of human netrin binding membrane receptor unc5h-1
WO2002018566A3 (en) Regulation of human l-asparaginase-like enzyme
WO2002046403A3 (en) Regulation of human patched-like protein
WO2003072767A3 (en) Regulation of human lipase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001954005

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10312831

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001954005

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001954005

Country of ref document: EP